Stryker launches Incompass total ankle system
September 9, 2025
Stryker (NYSE: SYK)+
today announced the launch of its recently FDA-cleared Incompass total ankle system.
Stryker (NYSE: SYK)+
today announced the launch of its recently FDA-cleared Incompass total ankle system.
Philips (NYSE: PHG)+ today announced the introduction of a new telemetry platform aiming to address critical challenges in healthcare.
Dolphin Life Science India handles the local production of the TRIA mitral valve.
Tasso, a specialist in patient-centric blood collection, and SheMed, a UK-based women’s healthcare company, have teamed up to deliver safer, more personalised weight loss treatments through convenient at-home diagnostics.
The NeuViz P10 uses a cadmium zinc telluride detector to directly convert X-ray photons, thereby eliminating light conversion.
HeartFocus announced today that it began the U.S. commercial launch for its AI-enabled cardiac imaging software on Butterfly Network devices.
Philips (NYSE: PHG)+ announced today that it launched Transcend Plus, the next generation of its cardiovascular ultrasound offerings.
Boston Scientific (NYSE: BSX)+
announced today that it initiated a new trial to assess its Agent DCB compared to the standard of care.
BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic (IVD) test cleared by the U.S. Food and Drug Administration (FDA) to aid in the diagnosis of Alzheimer’s disease.
WEST DUNDEE, Ill., Aug. 14, 2025 /PRNewswire/ — Those seeking help with depression or anxiety can now benefit from an FDA-cleared, medication-free procedure at Dundee Dermatology. The center is showcasing EXOMIND, a noninvasive neurostimulation device that enhances mental wellness.